Comparison of Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Bmab 1000 and Prolia® in Normal Healthy Volunteers: DENARIUS: DENosumab Pharmacokinetic equivAlence tRIal in Healthy volUnteerS
Clinical trial NCT05323708 · COMPLETED
Trial details
- NCT number
- NCT05323708
- Sponsor
- Biocon Biologics UK Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-09
- Primary completion
- 2023-10-06
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.